You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

ALPROSTADIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Alprostadil, and when can generic versions of Alprostadil launch?

Alprostadil is a drug marketed by Hikma and Meitheal and is included in two NDAs.

The generic ingredient in ALPROSTADIL is alprostadil. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the alprostadil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Alprostadil

A generic version of ALPROSTADIL was approved as alprostadil by HIKMA on January 20th, 1998.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ALPROSTADIL?
  • What are the global sales for ALPROSTADIL?
  • What is Average Wholesale Price for ALPROSTADIL?
Drug patent expirations by year for ALPROSTADIL
Recent Clinical Trials for ALPROSTADIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Hospital, RouenPhase 3
Kafrelsheikh UniversityN/A
The First Hospital of Jilin UniversityPhase 4

See all ALPROSTADIL clinical trials

Medical Subject Heading (MeSH) Categories for ALPROSTADIL

US Patents and Regulatory Information for ALPROSTADIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma ALPROSTADIL alprostadil INJECTABLE;INJECTION 074815-001 Jan 20, 1998 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Meitheal ALPROSTADIL alprostadil INJECTABLE;INJECTION 075196-001 Apr 30, 1999 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.